Dr. Jana Hirschtick | Social Sciences | Best Researcher Award

Advocate Health, United States

Dr. Jana Hirschtick is an accomplished public health researcher and epidemiologist whose work spans infectious disease epidemiology, population health, and health equity. She earned her advanced degrees in public health and epidemiology, equipping her with strong methodological and analytical expertise that underpins her research excellence. Over her career, she has held key professional roles in academia and public health institutions, leading large-scale, federally funded studies and collaborating across multidisciplinary teams to address pressing health challenges. Her research interests focus on understanding social determinants of health, tobacco use, COVID-19 outcomes, and chronic disease prevention, with a particular emphasis on vulnerable and underserved populations. Dr. Hirschtick possesses a diverse set of research skills, including epidemiologic study design, longitudinal and cross-sectional data analysis, biostatistics, computational modeling, and translating research findings into policy-relevant insights. She has been recognized for her scholarly contributions with multiple awards and honors that reflect her leadership, innovation, and impact in public health research, including commendations for mentoring emerging scientists and advancing health equity initiatives. Her strengths lie in rigorous methodology, interdisciplinary collaboration, mentorship, and the ability to generate actionable, evidence-based solutions to complex health challenges. While expanding her global research collaborations and further integrating advanced computational approaches could enhance the scope of her work, her future research potential is exceptional, with opportunities to advance understanding of post-acute sequelae of infectious diseases, chronic disease prevention, and the intersection of social factors with health outcomes. Overall, Dr. Hirschtick exemplifies the qualities of a visionary public health leader whose dedication, expertise, and forward-looking research agenda position her to make transformative contributions to population health, health equity, and the training of future epidemiologists, making her highly deserving of recognition and accolades in her field.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Muehlenbein, M. P., Hirschtick, J. L., Bonner, J. Z., & Swartz, A. M. (2010). Toward quantifying the usage costs of human immunity: Altered metabolic rates and hormone levels during acute immune activation in men. American Journal of Human Biology: The Official Journal of the Human Biology Association, 22(4), 546–556.
2. Hirschtick, J. L., Titus, A. R., Slocum, E., Power, L. E., Hirschtick, R. E., Elliott, M. R., … & Cadham, C. J. (2021). Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clinical Infectious Diseases, 73(11), 2055–2064.
3. Cadham, C. J., Sanchez-Romero, L. M., Fleischer, N. L., Mistry, R., Hirschtick, J. L., … & Brouwer, A. F. (2020). The actual and anticipated effects of a menthol cigarette ban: A scoping review. BMC Public Health, 20(1), 1055.
4. Brouwer, A. F., Jeon, J., Hirschtick, J. L., Jimenez-Mendoza, E., Mistry, R., … & Cadham, C. J. (2022). Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1–4): Multistate transition modelling accounting for complex survey design. Tobacco Control, 31(3), 424–431.
5. Needham, B. L., Ali, T., Allgood, K. L., Ro, A., Hirschtick, J. L., Fleischer, N. L. (2023). Institutional racism and health: A framework for conceptualization, measurement, and analysis. Journal of Racial and Ethnic Health Disparities, 10(4), 1997–2019.